Executive Change

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549  _______________ FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934  _______________ Date of Report:   June 1, 2019 (Date of earliest event reported)  _______________ TENET HEALTHCARE CORP ORATION (Exact name of Registrant as specified in its charter)           Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 1445 Ross Avenue , Suite 1400 Dallas , Texas   75202 (Address of principal executive offices, including zip code) ( 469 ) 893-2200 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, $0.05 par value   THC   New York Stock Exchange 6.875% Senior Notes due 2031   THC31   New York Stock Exchange Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ¨   Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 6, 2019, Tenet Healthcare Corporation (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) to report that the Company’s Board of Directors (the “Board”) appointed Christopher S. Lynch to the Board, effective on August 7, 2019. Mr. Lynch had not yet been appointed to serve on any committees of the Board as of the Original Report. The Company is filing this amendment to the Original Report to report that, on August 7, 2019, the Board appointed Mr. Lynch to serve as a member of the Board’s Audit Committee and Human Resources Committee, effective immediately. Item 9.01. Financial Statements and Exhibits. (d) Exhibits 104   Cover page from Tenet Healthcare Corporation’s Current Report on Form 8-K filed on August 9, 2019, formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.               TENET HEALTHCARE CORPORATION         Date: August 9, 2019   By:   /s/ Anthony Shoemaker         Anthony Shoemaker         Vice President, Assistant General Counsel and Corporate Secretary